Amendment107th Congress
Amendment reallocates FDA funding of $1 million to the Office of Generic Drugs to evaluate and review potential patent abuse.
- Amendment Number
- 163
- Description
- Amendment reallocates FDA funding of $1 million to the Office of Generic Drugs to evaluate and review potential patent abuse.
- Purpose
- An amendment to increase the funding by $1,000,000 for responsibilities of the FDA with respect to abbreviated applications for the approval of new drugs.
- Congress
- 107
- Type
- HAMDT
- Latest Action Date
- Jul 11, 2001
- Latest Action Text
- On agreeing to the Brown (OH) amendment (A031) Agreed to by voice vote.
- Latest Action Time
- 17:27:04
- Submitted Date
- Jul 11, 2001
- Chamber
- House of Representatives
- Update Date
- Aug 15, 2021